Tetrodotoxin |
TTX |
0.5 µM |
Na+ channel blocker |
Tocris, 1069 and Cayman, 14964 |
Kisspeptin-10 |
KP |
10 or 100 nM |
Kiss1r agonist |
Tocris, 4243 and Phoenix Pharmaceuticals Inc., 048–56 |
Okadaic acid |
OKA |
30 nM |
Protein phosphatase 1 and 2A inhibitor |
Cayman, 10011490 |
N-acetoyl-D-erythro-sphingosine |
C2 ceramide |
20 µM |
Protein phosphatase A2 activator |
Cayman, 62510 |
Bisindolylmaleimide X |
BIM X |
100 nM |
Protein kinase C inhibitor |
Cayman, 17511 |
2-Aminoethoxydi-phenylborane |
2-APB |
75 µM |
TRPC1, TRPC3, TRPC5, and TRPC6 blocker & IP3 receptor blocker |
Cayman, 64970 |
Nifedipine |
Nif |
1 µM |
L-type voltage-gated calcium channel blocker |
Sigma, N7634 |
ω-conotoxin GVIA |
Ctx GVIA |
100 nM |
N-type voltage-gated calcium channel blocker |
Sigma, C9915 |
SKF96365 |
SKF96365 |
30 µM |
TRPC6, TRPC7 blocker |
Tocris, 1147 |
Lanthanum |
La3+
|
100 µM |
TRPC3, TRPC4/5, TRPC6, TRPC7 blocker |
Sigma, 449830 |
Flufenamic acid |
FFA |
100 µM |
TRPC3, TRPC5, and TRPC7 inhibitor |
Sigma, F9005 |
Wortmannin |
Wort [nM] |
100 nM |
PI3K inhibitor |
Cayman 10010591 |
Wortmannin |
Wort [µM] |
10 µM |
PI4K inhibitor |
Diethylamine NONOate |
DEA/NO |
100 µM |
NO donor |
Cayman 82100 |
8-pCPT-cGMP |
cGMP |
200 µM |
GMP-dependent protein kinase activator |
Sigma, C5438 |
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one |
ODQ |
30 µM |
NO-sensitive guanylyl cyclase inhibitor |
Cayman, 81410 |
Y27632 |
Y27632 |
10 µM |
ROCK-I and ROCK-II inhibitor |
MedChemExpress, HY-10583 |